U.S., Feb. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07398014) titled 'The New Possibility of Treating Overactive Bladder With Radiofrequency' on Sept. 05, 2025.
Brief Summary: A prospective, randomized, single-blind, placebo-controlled study was conducted from June 2023 to May 2025. The study enrolled 95 women (N=48 in the study group; N=47 in the placebo group) who presented with confirmed symptoms of OAB and UUI prior to enrollment. Symptom severity and quality of life were assessed using validat-ed questionnaires from the International Consultation on Incontinence Questionnaires (ICIQ), specifically ICIQ-OAB, ICIQ-OABqol, and ICIQ-FLUTSsex. A higher score on these questionnaires indicated a worse q...